News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
479,818 Results
Type
Article (25221)
Company Profile (170)
Press Release (454427)
Section
Business (141434)
Career Advice (744)
Deals (25497)
Drug Delivery (46)
Drug Development (54651)
Employer Resources (70)
FDA (12170)
Job Trends (10295)
News (235995)
Policy (19634)
Tag
Academia (1909)
Alliances (40277)
Alzheimer's disease (929)
Approvals (12143)
Artificial intelligence (153)
Bankruptcy (208)
Best Places to Work (8860)
Biotechnology (135)
Breast cancer (126)
Cancer (1052)
Cardiovascular disease (88)
Career advice (655)
CAR-T (83)
Cell therapy (242)
Clinical research (43411)
Collaboration (431)
Compensation (123)
COVID-19 (1630)
C-suite (94)
Data (1160)
Diabetes (107)
Diagnostics (5455)
Earnings (52660)
Events (69191)
Executive appointments (301)
FDA (12737)
Funding (348)
Gene therapy (172)
GLP-1 (301)
Government (2316)
Healthcare (13217)
Infectious disease (1703)
Inflammatory bowel disease (80)
Interviews (100)
IPO (11989)
Job creations (1824)
Job search strategy (576)
Layoffs (161)
Legal (3844)
Lung cancer (139)
Manufacturing (155)
Medical device (12076)
Medtech (12081)
Mergers & acquisitions (13721)
Metabolic disorders (277)
Neuroscience (1141)
NextGen Class of 2024 (4510)
Non-profit (2328)
Northern California (1317)
Obesity (150)
Opinion (135)
Patents (105)
People (39579)
Phase I (14737)
Phase II (19388)
Phase III (13722)
Pipeline (424)
Postmarket research (1106)
Preclinical (6111)
Radiopharmaceuticals (207)
Rare diseases (212)
Real estate (3879)
Regulatory (14423)
Research institute (1822)
Resumes & cover letters (110)
Southern California (1146)
Startups (2838)
United States (11783)
Vaccines (335)
Weight loss (85)
Date
Today (2)
Last 7 days (303)
Last 30 days (1783)
Last 365 days (27789)
2024 (27686)
2023 (31970)
2022 (41701)
2021 (44364)
2020 (41675)
2019 (33926)
2018 (25191)
2017 (24659)
2016 (22998)
2015 (26789)
2014 (19773)
2013 (16207)
2012 (17281)
2011 (17843)
2010 (16345)
Location
Africa (455)
Arizona (112)
Asia (31712)
Australia (6332)
California (2962)
Canada (1129)
China (229)
Colorado (139)
Connecticut (150)
Europe (63578)
Florida (429)
Georgia (104)
Illinois (260)
Indiana (195)
Kansas (79)
Maryland (464)
Massachusetts (2265)
Michigan (159)
Minnesota (218)
New Jersey (896)
New York (850)
North Carolina (576)
Northern California (1317)
Ohio (109)
Pennsylvania (692)
South America (711)
Southern California (1146)
Texas (432)
Utah (98)
Washington State (354)
479,818 Results for "genetic technologies limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Genetic Technologies Limited is pleased to invite investors to a webinar on June 27, 2024, at 4:15 p.m. ET.
June 21, 2024
·
3 min read
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
Genetic Technologies Limited, a global leader in genomics-based tests in health, wellness and serious disease, announced its plans to effect.
December 12, 2023
·
2 min read
Genetic Technologies Announces $2 Million Registered Direct Offering
Genetic Technologies Limited announced that it has entered into a definitive agreement for the purchase and sale in a registered direct offering of 1,000,000 American Depositary Shares, each representing thirty ordinary shares of the Company, at a purchase price of $2.00 per ADS.
April 18, 2024
·
5 min read
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
Genetic Technologies Limited announces the closing of its previously announced registered offering for the purchase and sale of 1,000,000 American Depositary Shares, each representing thirty ordinary shares of the Company, at an offering price of US$2.00 per ADS.
April 22, 2024
·
5 min read
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
Genetic Technologies Limited is pleased to report the company’s new digital strategy, led by the company’s recently appointed strategic advisor, Dr. Malcolm Bohm, is having a significant positive impact across all facets of GTG’s social media platforms.
April 2, 2024
·
4 min read
Genetic Technologies Limited Announces Updated Investor Presentation
Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG, “Company”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to provide an update on the company’s activities via the latest investor presentation attached.
August 9, 2023
·
2 min read
BioMidwest
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, published in Nature Genetics scientific findings that highlights a potential limitation of CRISPR-Cas9 in gene editing - a key component in understanding disease mechanisms, and developing new therapeutic approaches.
May 29, 2024
·
5 min read
Press Releases
Microbix Assisting EMQN with Novel Genetic-Test EQA Program
December 10, 2024
·
5 min read
Press Releases
Dynavax Adopts Limited-Duration Stockholder Rights Plan
October 30, 2024
·
5 min read
Policy
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
Genetic Technologies Limited a global leader in genomics-based tests in health, wellness, and serious disease, advises that it has received formal notice from the Nasdaq Stock Market, LLC stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550.
January 5, 2024
·
1 min read
1 of 47,982
Next
